The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and Cervical Intraepithelial Neoplasia (CIN) Patients and Their Prognosis
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00728871|
Recruitment Status : Unknown
Verified August 2008 by National Taiwan University Hospital.
Recruitment status was: Recruiting
First Posted : August 6, 2008
Last Update Posted : August 6, 2008
A. To investigate the relationship between serum titer of anti-HPV16 antibody and clinicopathological factors of cervical cancer patients.
B. To investigate that if the serum titer of anti-HPV16 antibody could be a prognostic factor in the cervical cancer patients.
C. To investigate the serum titer of anti-HPV16 antibody in HPV16-infected populations with various disease status such as infection only, precancerous lesion, and early and advanced cervical cancer.
|Condition or disease||Intervention/treatment|
|Cervical Cancer Cervical Intraepithelial Neoplasia||Procedure: peripheral blood isolation|
Show Detailed Description
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||600 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Primary Purpose:||Basic Science|
|Official Title:||The Correlations Between HPV L1-Specific Immunologic Responses in Cervical Cancer and CIN Patients and Their Prognosis|
|Study Start Date :||December 2005|
|Estimated Primary Completion Date :||January 2006|
|Estimated Study Completion Date :||December 2011|
Procedure: peripheral blood isolation
- overall survival [ Time Frame: from CS operation to close ]
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00728871
|Contact: Chi-An Chen, MD||886-2-2312-3456 ext email@example.com|
|Natioanal Taiwan Univ. Hospital||Recruiting|
|Taipei, Taiwan, China, 100|
|Contact: Chi-An Chen, MD 886-2-2312-3456 ext 5166 firstname.lastname@example.org|
|Study Chair:||Chi-An Chen, MD||National Taiwan University Hospital|
|Study Chair:||Chi-An Chen, MD||National Taiwan Univ. Hosp.|